$63.06 2.2%
TMDX Stock Price vs. AI Score
Data gathered: December 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - TransMedics Group (TMDX)

Analysis generated September 28, 2024. Powered by Chat GPT.

TransMedics Group, Inc. (NASDAQ: TMDX) is an innovative medical technology company specializing in organ transplant systems. Their flagship product, the Organ Care System (OCS), revolutionizes organ preservation, making it possible to monitor and maintain organs in a near-physiologic, functioning state outside the body. The company's breakthrough technology aims to improve the outcomes of organ transplantation, targeting significant unmet needs in the healthcare industry.

Read full AI stock Analysis

Stock Alerts - TransMedics Group (TMDX)

company logo TransMedics Group | December 18
Price is down by -5.1% in the last 24h.
company logo TransMedics Group | December 6
AI Score is down by 25.6% in the last couple of days.
company logo TransMedics Group | December 5
Price is down by -5.4% in the last 24h.
company logo TransMedics Group | December 5
Insider Alert: Khayal Tamer I is selling shares

About TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.


TransMedics Group
Price $63.06
Target Price Sign up
Volume 325,980
Market Cap $2.07B
Year Range $60.53 - $176.11
Dividend Yield 0%
PE Ratio 66.34
Analyst Rating 75% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24109M48M61M4.2M4M0.120
Q2 '24114M45M69M12M16M0.350
Q1 '2497M37M60M12M16M0.350
Q4 '2381M33M48M4M6.3M0.120
Q3 '2366M26M41M-25M-23M-0.780

Insider Transactions View All

Khayal Tamer I filed to sell 20,843 shares at $86.4.
December 4 '24
Hassanein Waleed H filed to sell 61,643 shares at $135.
October 17 '24
Hassanein Waleed H filed to sell 61,943 shares at $134.2.
October 17 '24
Hassanein Waleed H filed to sell 63,143 shares at $132.8.
October 17 '24
Hassanein Waleed H filed to sell 66,661 shares at $131.9.
October 17 '24

What is the Market Cap of TransMedics Group?

The Market Cap of TransMedics Group is $2.07B.

What is TransMedics Group's PE Ratio?

As of today, TransMedics Group's PE (Price to Earnings) ratio is 66.34.

What is the current stock price of TransMedics Group?

Currently, the price of one share of TransMedics Group stock is $63.06.

How can I analyze the TMDX stock price chart for investment decisions?

The TMDX stock price chart above provides a comprehensive visual representation of TransMedics Group's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling TransMedics Group shares. Our platform offers an up-to-date TMDX stock price chart, along with technical data analysis and alternative data insights.

Does TMDX offer dividends to its shareholders?

As of our latest update, TransMedics Group (TMDX) does not offer dividends to its shareholders. Investors interested in TransMedics Group should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of TransMedics Group?

Some of the similar stocks of TransMedics Group are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.